Association of microscopic colitis and enteropathy due to olmesartan

Lucía Seoane Blanco1, Brais Fernández Suárez2, María Gómez Rivas2

  • 1Digestivo, Hospital Universitario Lucus Augusti (HULA), España.

Insights

A patient with chronic diarrhea was diagnosed with microscopic colitis and Olmesartan-induced enteropathy. This rare concurrent diagnosis highlights the need for thorough medical history and clinical suspicion in diagnosing uncommon gastrointestinal conditions.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Chronic diarrhea poses a diagnostic challenge, often requiring extensive investigation.
  • Olmesartan, a widely used antihypertensive, is associated with gastrointestinal side effects.
  • Microscopic colitis is an inflammatory condition of the colon.

Observation:

  • A patient presented with recurrent, severe chronic diarrhea of unknown etiology.
  • Despite multiple admissions and investigations, the cause of the diarrhea remained elusive.
  • A detailed medical history and further studies were crucial for diagnosis.

Findings:

  • The patient was diagnosed with concurrent microscopic colitis and Olmesartan-induced enteropathy.
  • This combination of conditions is rarely reported in medical literature.
  • Olmesartan was identified as the causative agent for the enteropathy.

Implications:

  • Emphasizes the importance of a comprehensive patient history in diagnosing complex gastrointestinal disorders.
  • Highlights the need for high clinical suspicion to identify uncommon drug-induced enteropathies.
  • Suggests that early diagnosis can prevent unnecessary investigations and treatments for chronic diarrhea.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
184
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450